Skip to content

PartiX

Active
KBO/BCE: BE 0773.403.170
Watch Print / PDF
Full dossier in preparation

Checked processes every Belgian company, act by act, from the Belgian Official Gazette. The data below is real and verified, this company's full, act-by-act verified dossier is still being assembled.

Process with priority Sign in free to move this company to the front.
Age4 yrs
Board4
Staff (FTE)1
Connections6
Real estate1 parcel · 10.3 ha

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of PartiX is 0.6% (low). The 2025 annual accounts show equity of €122k and a net result of €-882. Equity is growing by ~4.8% per year across the filed fiscal years. Its solvency ranks better than 92% of 43 sector peers (fiscal year 2025). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 4 annual accounts.

Signals

1 signal · with evidence
Strong solvency vs sector
Solvency is in the sector's strongest quartile: better than 92% of 43 peers (2025). A comfortable equity buffer.
View the sector comparison

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide
Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-05-2026, 79 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
How we compute the deadline
The year end is derived from 4 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2025, that is 31-07-2026.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 13-05-2026 79 d early 2026-00111106
31-12-2024 31-07-2025 10-07-2025 21 d early 2025-00267463
31-12-2023 31-07-2024 16-05-2024 76 d early 2024-00090835
31-12-2022 31-07-2023 15-06-2023 46 d early 2023-00132298

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
More than 3 years active
Founded in 2021, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.6% Low
0%0,5%1,5%4%10%≥25%
Young company +Lower-failure-rate sector −Lower-risk legal form −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€-882
Working capital€62k-24.8%

Annual accounts & ratios

Source: NBB · 2025
Annual accounts filed on 13-05-2026 with the NBB · fiscal year 2025 · verkort
€-5k€0€5k€10kOperating result 2022: €11k€11kNet result 2022: €9k€9kOperating result 2023: €7k€7kNet result 2023: €6k€6kOperating result 2024: €10k€10kNet result 2024: €8k€8kOperating result 2025: €-350€-350Net result 2025: €-882€-8822022202320242025
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing Equity: growth of ~4.8%/year over 4 fiscal years, indicative, assuming unchanged policy.
€100k€120k€140k€160k2026: €132k (€122k - €142k)2027: €139k (€129k - €148k)2028: €145k (€136k - €155k)2022: €109k2023: €115k2024: €123k2025: €122k2022202320242025202620272028
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2025 · NACE 74 · compared within the same schema type (abbreviated schema)
Metric This company Sector median Position in the sector
Solvency 94.5% 47.1%
better than 92% of 43 sector peers
Net result €-882 €27k
better than 25% of 43 sector peers
Equity €122k €92k
better than 61% of 43 sector peers
Gross operating margin €81k €64k
better than 55% of 43 sector peers
Total assets €129k €226k
better than 30% of 43 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P92
2022: P95 · n=612023: P95 · n=882024: P95 · n=1062025: P92 · n=432022 2025
Stable position over 2022-2025 · n=43-106
Net result P25
2022: P50 · n=612023: P44 · n=882024: P48 · n=1062025: P25 · n=432022 2025
Weakening position over 2022-2025 · n=43-106
Equity P61
2022: P55 · n=612023: P61 · n=882024: P59 · n=1062025: P61 · n=432022 2025
Stable position over 2022-2025 · n=43-106
Gross operating margin P55
2022: P33 · n=612023: P28 · n=882024: P32 · n=1072025: P55 · n=432022 2025
Improving position over 2022-2025 · n=43-107
Describes the position versus peers, not a forecast.
EBITDA
€15k
-28.5% 22-25
Net profit
€-882
- 22-25
Cash flow
€14k
-22.1% 22-25
Total assets
€129k
+2.6% 22-25
Equity
€122k
-0.7% 22-25
Working capital
€62k
-24.8% 22-25
Employees (FTE)
1
- 22-25
Staff costs
€67k
- 22-25
Income taxes
€97
-95.7% 22-25
Debt
€7k
+135.2% 22-25
Debt ≤ 1y
€7k
+135.2% 22-25
Current ratio
9.66
-65.6% 22-25
Quick ratio
9.66
-65.6% 22-25
Solvency
94.5%
-3.2% 22-25
Debt / equity
0.06
+136.9% 22-25
ROE
-0.7%
- 22-25
ROA
-0.7%
- 22-25
Interest coverage
26.42
-83.7% 22-25
Figures by fiscal year
Fiscal year2025
Depositverkort
Revenue-
EBITDA€15k
Net profit€-882
Cash flow€14k
Staff costs€67k
Income taxes€97
Dividends-
Total assets€129k
Equity€122k
Debt€7k
of which ≤ 1y€7k
of which > 1y-
Working capital€62k
Employees (FTE)1.0
Ratios (computed)
2025
Current ratio9.66
Quick ratio9.66
Working capital ratio47.9%
Solvency94.5%
Debt / equity0.06
Long-term debt ratio-
Interest coverage26.42
Gross margin-
Net margin-
ROA-0.7%
ROE-0.7%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2025
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2025
Balance sheet, Assets
TOTAL ASSETS 20/58€129k
Fixed assets 21/28€60k
Intangible fixed assets 21€50k
Tangible fixed assets 22/27€10k
Current assets 29/58€69k
Amounts receivable within one year 40/41€49k
Cash & bank 54/58€18k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€129k
Equity 10/15€122k
Contributions / capital 10/11€100k
Reserves 13€22k
Amounts payable 17/49€7k
Amounts payable within one year 42/48€7k
Trade debts payable within one year 44€1k
Income statement
Gross operating margin 9900€81k
Operating result 9901€-350
Financial income 75€123
Financial charges 65€559
Result before taxes 9903€-785
Income taxes 67/77€97
Net result for the period 9904€-882
Result to be appropriated 9905€-882
You're seeing the latest fiscal year only. Unlock 3 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2025 · computed
70 / 100 Healthy
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Directors

Directors & mandates

under verification
Directors derived from a single State Gazette act, under verification
All 4 current directors first appear in the same act (25129667). Founders or capital subscribers may have been counted as directors here; the real board composition is being verified.
Current directors & mandates
  • Pescod Russel
    Managing director
    State Gazette act 25129667 (13-10-2025)
    Current
    02-05-2025 → present
    4 events
    • 02-05-2025 Resigned· Managing director
    • 02-05-2025 Appointed· Managing director
    • 02-05-2025 Resigned· Director
    • 02-05-2025 Appointed· Director
  • Van der Gucht Filip
    Director
    State Gazette act 25129667 (13-10-2025)
    Current
    02-05-2025 → present
    2 events
    • 02-05-2025 Resigned· Director
    • 02-05-2025 Appointed· Director
  • Vansant Peter
    Director
    State Gazette act 25129667 (13-10-2025)
    Current
    02-05-2025 → present
  • Vansant Stijn
    Director
    State Gazette act 25129667 (13-10-2025)
    Current
    02-05-2025 → present
Former directors (2)
  • Jacobs Marc
    Director
    State Gazette act 25129667 (13-10-2025)
    Former
    - → 02-05-2025
  • Vansant Jan
    Director
    State Gazette act 25129667 (13-10-2025)
    Former
    - → 02-05-2025
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.

Insolvency mandates

No insolvency mandates (liquidators, administrators) on record for this company.

Legal Structure

NACE primary Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg(74999)
Legal form Public limited company(014)
Incorporation01-09-2021
StatusActive
Postal code3010

Structure & network

Connections & network

6 connected companies
Metaptys, Shared address MMetaptysMolecular Plasma Group, Shared address MPMolecularPlasma GroupONCO3R Therapeutics, Shared address OTONCO3RTherapeuticsQUOMAK, Shared address QQUOMAKReWind Therapeutics, Shared address RTReWindTherapeuticsTavira Therapeutics, Shared address TTTaviraTherapeuticsPartiX PartiX0773.403.170
Shared address / shareholder
Network connections
Metaptys
Shared address
→
→
ONCO3R Therapeutics
Shared address
→
QUOMAK
Shared address
→
ReWind Therapeutics
Shared address
→
Tavira Therapeutics
Shared address
→
Connections derived from shared directors, addresses, shareholders and group structure in the Belgian State Gazette.

Locations & real estate

Registered office

on the map · from the address register
exact location from the address register On OpenStreetMap
3 companies at this address See who is registered here

Establishment units

1 location
PartiX
Diestsesteenweg 682, 3010 LeuvenOnderzoek en op punt stellen van de productie van actief geneeskrachtige substanties, bestemd voor de vervaardiging van geneesmiddelen
since 20212.320.995.709
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area10.3 ha
Buildings1
Building footprint3.8 ha
Volume (LiDAR)289,124 m³
Tallest building18.7 m · ±2 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
24483D0031/00R000 Flanders 10.3 ha 1 · 3.8 ha 18.7 m · 2 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

3 acts
Address history · 1
29-08-2024
v3.2
All acts · 3 updated 10 months ago
2025
13-10-2025 5 directors appointed, 5 resigning Director changes
  • Pescod Russel, Gedelegeerd bestuurder
  • Pescod Russel, Bestuurder
  • Van der Gucht Filip, Bestuurder
  • Vansant Stijn, Bestuurder
  • Vansant Peter, Bestuurder
  • Pescod Russel, Gedelegeerd bestuurder
  • Jacobs Marc, Bestuurder
  • Pescod Russel, Bestuurder
Summary: v3.2
2024
29-08-2024 Registered office moved within Leuven Registered-office change
  • Gaston Geenslaan 1, 3001 Leuven → Gaston Geenslaan 3, 3001 Leuven
Summary: v3.2
2021
03-09-2021 Incorporation of a new NV Incorporation
Summary: oprichting

Analysis

Snowflake analysis

financial profile on 5 axes
Health70Profitability0Solvency100Growth52Stability94
63 / 100

Strong profile, led by solvency.

All 5 axes are computed from data Checked has read.

Health 70
Profitability 0
Solvency 100
Growth 52
Stability 94

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Comparable size, same sector
We hold annual accounts for 724 of the 4,554 companies in this sector. 557 of them are within a factor 10 of this company's equity.

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72109Overige gespecialiseerde wetenschappelijke en technische activiteiten74909Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg74999Vervaardiging van andere machines, apparaten en werktuigen voor specifieke doeleinden, n.e.g.28990Vervaardiging van andere machines voor specifieke doeleinden neg28990Computerconsultancy-activiteiten62020Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten62200Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72109Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72190
Primary activity highlighted.
Names & trade names
Legal nameNL PartiX
Registered office
Diestsesteenweg 682 bus e4
3010 Leuven, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.